Fatigue in people with Parkinson's disease - its scale and consequences for activity and quality of life
Related Experiment Video
Updated: Jan 6, 2026

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer
Published on: February 20, 2020
Justyna A Szefler-Derela1, Martin Helisz2, Julia Gawron3
1Department of Physiotherapy, Faculty of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Introduction:
Fatigue is one of the most common and distressing non-motor symptoms in Parkinson's disease, affecting up to half of patients. As a multidimensional symptom - encompassing physical, emotional, and cognitive aspects - it significantly reduces quality of life and daily functioning. It often appears in the early stages of the disease, and its subjective nature complicates its clear clinical definition. Despite its importance, fatigue is often underdiagnosed and rarely considered in routine care.
Clinical Rationale For The Study:
Fatigue in Parkinson's disease is often an underestimated symptom, despite its significant impact on quality of life and daily functioning, often more so than motor symptoms. Its impact on physical activity - a key factor in slowing disease progression - underscores the need to better recognize and incorporate this symptom into clinical practice. The study results may support the development of more effective and personalized therapeutic strategies.
Material And Methods:
The study included 107 patients with Parkinson's disease (PD), with Hoehn and Yahr scale (H&Y) disease stages I [n = 13 (12%)], II [n = 15 (14%)], III [n = 53 (50%)], and IV [n = 25 (23%)]; ages ranged from 35 to 86 years; and disease duration ranged from 0 to 33 years (Median = 7.00 years). The study tool was a questionnaire. Fatigue levels were assessed using two scales: the Parkinson's fatigue scale (PFS-16) and the fatigue severity scale (FSS). Physical activity and quality of life were examined with the Parkinson's disease questionnaire (PDQ-39).
Results:
The questionnaires used (FSS, PFS, PDQ-39) demonstrated high reliability (Cronbach's alpha: 0.93-0.96) and no floor/ /ceiling effects. Fatigue was reported in 57% of the participants, slightly more often in women, although the differences were not statistically significant. Disease duration was significantly longer in men (p < 0.01). Fatigue correlated with activity level (p < 0.01) and quality of life across all PDQ-39 domains.
Conclusions:
Fatigue is a common and significant problem across all stages of Parkinson's disease. The FSS, PFS, and PDQ-39 questionnaires are reliable tools for assessing fatigue in people with PD. Fatigue has a significant impact on quality of life and activity levels. Further, multifaceted research is needed to clarify this issue.
More Related Videos
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
09:19Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
Published on: December 9, 2014
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Fatigue
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
COPD: Management Using Bronchodilators and Corticosteroids
Heart Failure VII: Nursing Interventions